Regarding comorbidities, significantly higher levels of C-RP were rendered by insulin-resistant subjects, and significantly higher levels of ferritin among those suffering from NAFLD; no other differences were detected in cytokine levels as regards metabolic comorbidities (Table 2). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.